Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Braz. j. med. biol. res ; 49(8): e5341, 2016. tab, graf
Article in English | LILACS | ID: lil-787390

ABSTRACT

Lymph node metastases are an independent prognosis factor in gastric carcinoma (GC) patients. Radical lymphadenectomy can improve survival but it can also increase surgical morbidity. As a principle, sentinel node (SN) navigation surgery can avoid unnecessary lymphadenectomy without compromising prognosis. In this pilot study, 24 patients with untreated GC were initially screened for SN navigation surgery, of which 12 were eligible. Five patients had T2 tumors, 5 had T3 tumors and 2 had T1 tumors. In 33% of cases, tumor diameter was greater than 5.0 cm. Three hundred and eighty-seven lymph nodes were excised with a median of 32.3 per patient. The SN navigation surgery was feasible in all patients, with a median of 4.5 SNs per patient. The detection success rate was 100%. All the SNs were located in N1 and N2 nodal level. In 70.9% of cases, the SNs were located at lymphatic chains 6 and 7. The SN sensitivity for nodal staging was 91.6%, with 8.3% of false negative. In 4 patients who were initially staged as N0, the SNs were submitted to multisection analyses and immunohistochemistry, confirming the N0 stage, without micrometastases. In one case initially staged as negative for nodal metastases based on SN analyses, metastases in lymph nodes other than SN were found, resulting in a 20% skip metastases incidence. This surgery is a reproducible procedure with 100% detection rate of SN. Tumor size, GC location and obesity were factors that imposed some limitations regarding SN identification. Results from nodal multisection histology and immunohistochemistry analysis did not change initial nodal staging.


Subject(s)
Humans , Rosaniline Dyes/administration & dosage , Stomach Neoplasms/surgery , Carcinoma/surgery , Technetium/administration & dosage , Sentinel Lymph Node Biopsy/methods , Carcinoma/pathology , Pilot Projects , Coloring Agents/administration & dosage , Neoplasm Grading , Lymph Nodes/pathology , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis
2.
Braz. j. med. biol. res ; 44(11): 1156-1163, Nov. 2011. ilus
Article in English | LILACS | ID: lil-604283

ABSTRACT

We evaluated the potential neuroprotective effect of 1-100 µM of four organoselenium compounds: diphenyl diselenide, 3’3-ditri-fluoromethyldiphenyl diselenide, p-methoxy-diphenyl diselenide, and p-chloro-diphenyl diselenide, against methylmercury-induced mitochondrial dysfunction and oxidative stress in mitochondrial-enriched fractions from adult Swiss mouse brain. Methylmercury (10-100 µM) significantly decreased mitochondrial activity, assessed by MTT reduction assay, in a dose-dependent manner, which occurred in parallel with increased glutathione oxidation, hydroperoxide formation (xylenol orange assay) and lipid peroxidation end-products (thiobarbituric acid reactive substances, TBARS). The co-incubation with diphenyl diselenide (100 µM) completely prevented the disruption of mitochondrial activity as well as the increase in TBARS levels caused by methylmercury. The compound 3’3-ditrifluoromethyldiphenyl diselenide provided a partial but significant protection against methylmercury-induced mitochondrial dysfunction (45.4 ± 5.8 percent inhibition of the methylmercury effect). Diphenyl diselenide showed a higher thiol peroxidase activity compared to the other three compounds. Catalase blocked methylmercury-induced TBARS, pointing to hydrogen peroxide as a vector during methylmercury toxicity in this model. This result also suggests that thiol peroxidase activity of organoselenium compounds accounts for their protective actions against methylmercury-induced oxidative stress. Our results show that diphenyl diselenide and potentially other organoselenium compounds may represent important molecules in the search for an improved therapy against the deleterious effects of methylmercury as well as other mercury compounds.


Subject(s)
Animals , Male , Mice , Brain/drug effects , Membrane Potential, Mitochondrial/drug effects , Mercury Poisoning, Nervous System/prevention & control , Methylmercury Compounds/toxicity , Mitochondria/drug effects , Neuroprotective Agents/pharmacology , Organoselenium Compounds/pharmacology , Oxidative Stress/drug effects , Analysis of Variance , Benzene Derivatives/pharmacology , Cell Fractionation , Models, Animal , Neuroprotective Agents/classification , Organoselenium Compounds/chemistry
3.
Rev. bras. otorrinolaringol ; 47(2): 127-40, 1981.
Article in Portuguese | LILACS | ID: lil-3651

ABSTRACT

Foram analisadas as caracteristicas da ocorrencia e intensidade do nistagmo espontaneo e semi-espontaneo a vecto-electronistagmografia, em 40 individuos considerados normais.Realizou-se avaliacao estatistica dos limites criticos da velocidade angular da componente lenta (VACL) do nistagmo espontaneo e semi-es pontaneo somente ocorreram com os olhos fechados em 12,5 e 5,0% dos normais. Em 80,0% dos casos, o nistagmo espontaneo foi horizontal para a direita e em 20,0% obliquo para cima e para a direita. O nistagmo semi-espontaneo sempre foi horizontal para a direita e acompanhado de nistagmo espontaneo de mesma direcao. Os limites criticos da VACL maxima e media do nistasmo espontaneo foram, respectivamente 6,6 e 4,2 graus por segundo. O limite critico da VACL media do nistagmo semi-espontaneo foi de 3,9 gruas por segundo


Subject(s)
Electronystagmography , Nystagmus, Pathologic
SELECTION OF CITATIONS
SEARCH DETAIL